DGE’s Investigator Initiated Trials Summit

On February 7-8th, 2022 in Philadelphia, DGE will hold the Investigator Trials Summit, which will provide delegates with the most up-to-date information on the full spectrum of challenges facing the industry: from reviewing proposals and aligning research with the corporation’s goals, to closing out studies and handling publication data, all while adhering to strict legal and regulatory frameworks on an international playing field.

The IIT Summit will feature sessions on the industry’s most pressing issues, such as multi-centered monitoring, assuring ROI, developing a publication strategy, and learning from practical case studies. Guest speakers, including Pfizer’s Alexander Kostek and Actelion Pharmaceuticals’ Joelle Rebetez, will lead in-depth and collaborative sessions as well as interactive panel discussions on a variety of timely issues.

The conference will feature a small-group format to encourage greater peer-to-peer networking and promote conversation among industry professionals, as well as customized workshops for pharmaceutical and medical device firms of all sizes.

Why Should You Attend?

Examine the complex regulatory requirements of sponsor-investigator research
Clarity on the importance of collaborating with key stakeholders to improve IITs
Advice on how to end a study while keeping the relationship with the investigator intact
The contrasts between an industry-sponsored study and Collaborative Research are summarized here
Key strategies for MSLs to effectively collaborate and manage an IIT
Best methods for including diversity and inclusion in funded studies
A guide to creating budgets, contracts, and determining fair market value

The conference will bring together clinician scientists, researchers, and professionals from research institutions, policymakers, industry, and regulatory organizations. By addressing current difficulties and showcasing creative solutions, the agenda will provide the groundwork for future success in investigator-initiated studies.

For more information, please visit https://dgevents.com/event/investigator-initiated-trials-summit/.

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.networknewswire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer